Café

© 2026 Longbridge｜Terms of Service Privacy Policy

ALPHAMAB-B

09966

7.4701.45% ( -0.110 )

Delay Closed: Jul 31, 16:08:00

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

The HK Market's Island of Misfit Toys: Who is Pivoting and Who is Sleepwalking?
Global Report·Jul 29 at 04:18 AM
02197+14.29%02408+1.88%
Liquidity spillovers trigger a structural repricing in Hong Kong's unclassified corners
Global Report·Jul 25 at 04:14 AM
09600-8.23%013410.00%
CSPC says China regulator grants breakthrough therapy designation for HER2-positive breast cancer combo
PUBT·Jul 14 at 06:01 AM
01093+0.35%300765+5.61%
CSPC PHARMA KN026 Combined with HB1801 for Breast Cancer Meets Primary Endpoint
AASTOCKS News·Jun 10 at 08:45 PM
01093+0.35%09966-1.45%
Top 10 HK Stock Losers (6.3)
Top Gainers&Losers·Jun 3 at 03:30 AM
01851+9.76%09900-0.20%
ALPHAMAB-BJSKN016 Clinical Study Results Presented at ASCO Annual Meeting
AASTOCKS News·Jun 1 at 08:15 PM
09966-1.45%
Alphamab Doses First Patient in Phase II Trial of JSKN033 for Advanced Cervical Cancer
Tip Ranks·May 12 at 07:07 PM
09966-1.45%
Alphamab’s KN026 Breast Cancer Trial Secures High-Profile ASCO 2026 Slot
Tip Ranks·Apr 21 at 11:07 PM
09966-1.45%520690-0.28%
Top 10 HK Stock Gainers (4.13)
Top Gainers&Losers·Apr 13 at 03:30 AM
01384+4.28%06090+4.22%
Top 10 HK Stock Gainers (4.1)
Top Gainers&Losers·Apr 1 at 03:30 AM
02513+14.56%02442+2.60%
Alphamab Oncology (9966) Gets a Buy from Jefferies
Tip Ranks·Mar 29 at 07:16 AM
FBT-3.01%09966-1.45%
ALPHAMAB-B (9966.HK) Technical Adjustment Warning
Technical Forecast·Mar 26 at 08:00 PM
09966-1.45%
Alphamab Starts Phase III Trial of Next-Gen HER2 Drug in High-Risk Breast Cancer
Tip Ranks·Mar 23 at 07:07 PM
513200+0.41%159316-0.18%
Alphamab Advances JSKN016 Into Phase III for Hard-to-Treat Breast Cancer
Tip Ranks·Mar 19 at 07:08 PM
588250+0.91%520880-0.46%